-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Femasys (NASDAQ:FEMY) Stock Price Down 0.8%
Femasys (NASDAQ:FEMY) Stock Price Down 0.8%
Femasys Inc. (NASDAQ:FEMY – Get Rating)'s stock price fell 0.8% during trading on Tuesday . The company traded as low as $1.18 and last traded at $1.21. 2,561 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,797 shares. The stock had previously closed at $1.22.
Analyst Ratings Changes
FEMY has been the subject of a number of recent analyst reports. Chardan Capital dropped their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 11th. HC Wainwright dropped their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday, October 20th.
Get Femasys alerts:Femasys Stock Performance
The company has a market capitalization of $14.30 million, a PE ratio of -1.53 and a beta of -0.23. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01. The firm's 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.41.
Femasys (NASDAQ:FEMY – Get Rating) last released its quarterly earnings data on Thursday, November 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.02). The company had revenue of $0.35 million during the quarter, compared to analysts' expectations of $0.40 million. Femasys had a negative net margin of 886.22% and a negative return on equity of 48.96%. On average, research analysts predict that Femasys Inc. will post -0.98 earnings per share for the current year.Institutional Investors Weigh In On Femasys
Several large investors have recently added to or reduced their stakes in the stock. Cetera Advisor Networks LLC bought a new stake in shares of Femasys in the 1st quarter valued at about $27,000. Virtu Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $39,000. HB Wealth Management LLC bought a new stake in shares of Femasys in the 4th quarter valued at about $49,000. LPL Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $51,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Femasys in the 1st quarter valued at about $68,000. 7.49% of the stock is owned by hedge funds and other institutional investors.
About Femasys
(Get Rating)
Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.
See Also
- Get a free copy of the StockNews.com research report on Femasys (FEMY)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.
Femasys Inc. (NASDAQ:FEMY – Get Rating)'s stock price fell 0.8% during trading on Tuesday . The company traded as low as $1.18 and last traded at $1.21. 2,561 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,797 shares. The stock had previously closed at $1.22.
Femasys Inc.（纳斯达克股票代码：FEMY — 获取评级）的股价在周二的交易中下跌了0.8％。该公司的交易价格低至1.18美元，最后一次交易价格为1.21美元。午盘交易中有2561股易手，较平均交易日成交量8,797股下降了71％。该股此前收于1.22美元。
Analyst Ratings Changes
分析师评级变化
FEMY has been the subject of a number of recent analyst reports. Chardan Capital dropped their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 11th. HC Wainwright dropped their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a research note on Thursday, October 20th.
FEMY一直是最近多份分析师报告的主题。Chardan Capital在11月11日星期五的一份研究报告中将Femasys股票的目标股价从15.00美元下调至12.00美元，并为该公司设定了 “买入” 评级。HC Wainwright在10月20日星期四的一份研究报告中将Femasys股票的目标股价从8.00美元下调至5.00美元，并为该公司设定了 “买入” 评级。
Femasys Stock Performance
Femasy 的股票表现
The company has a market capitalization of $14.30 million, a PE ratio of -1.53 and a beta of -0.23. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01. The firm's 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.41.
该公司的市值为1430万美元，市盈率为-1.53，beta值为-0.23。该公司的流动比率为9.56，速动比率为9.37，债务与权益比率为0.01。该公司的50天简单移动平均线为1.10美元，其200天简单移动平均线为1.41美元。
Institutional Investors Weigh In On Femasys
机构投资者对 Femasy 的看法
Several large investors have recently added to or reduced their stakes in the stock. Cetera Advisor Networks LLC bought a new stake in shares of Femasys in the 1st quarter valued at about $27,000. Virtu Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $39,000. HB Wealth Management LLC bought a new stake in shares of Femasys in the 4th quarter valued at about $49,000. LPL Financial LLC bought a new stake in shares of Femasys in the 2nd quarter valued at about $51,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Femasys in the 1st quarter valued at about $68,000. 7.49% of the stock is owned by hedge funds and other institutional investors.
几位大型投资者最近增加了或减少了在该股中的股份。Cetera Advisor Networks LLC在第一季度购买了Femasys的新股份，价值约27,000美元。Virtu Financial LLC在第二季度购买了Femasys股票的新股份，价值约为39,000美元。HB Wealth Management LLC在第四季度购买了Femasys的新股份，价值约49,000美元。LPL Financial LLC在第二季度购买了Femasys股票的新股份，价值约为51,000美元。最后，剑桥投资研究顾问公司在第一季度购买了价值约68,000美元的Femasys股票的新股份。该股中有7.49％由对冲基金和其他机构投资者持有。
About Femasys
关于 Femasys
(Get Rating)
（获取评分）
Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.
Femasys Inc是一家生物医学公司，专注于美国的女性医疗保健市场。该公司开发永久性节育解决方案，例如FemBloc和FemChec；FemMaSeed，一种人工授精解决方案；Femcerv，一种用于宫颈内膜刮宫的活检设备；以及支持子宫癌检测检测的子宫内膜采样候选产品FemmB。
See Also
另见
- Get a free copy of the StockNews.com research report on Femasys (FEMY)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- 免费获取 StockNews.com 关于 Femasys 的研究报告（FEMY）的副本
- Verizon、Charter在过去一个月中呈上升趋势：他们现在买了吗？
- 股息之王 Sysco：逢低买入
- Genius集团股票上涨1,600％是否合理？
- 经过进一步审查，投资者喜欢埃克森美孚的收益
- 卡特彼勒会挖掘另一个买入机会吗？
Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Femasys Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Femasys及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧